Topic Highlight Open Access
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Dec 28, 2014; 6(12): 890-894
Published online Dec 28, 2014. doi: 10.4329/wjr.v6.i12.890
Postoperative reactive lymphadenitis: A potential cause of false-positive FDG PET/CT
Yiyan Liu, Nuclear Medicine Service, Department of Radiology, Rutgers University Hospital, Newark, NJ 07103, United States
Author contributions: Liu Y solely contributed this work.
Correspondence to: Yiyan Liu, MD, PhD, Nuclear Medicine Service, Department of Radiology, Rutgers University Hospital, 150 Bergen Street, H141, Newark, NJ 07103, United States. liuyl@njms.rutgers.edu
Telephone: +1-973-9726022 Fax: +1-973-9726954
Received: April 30, 2014
Revised: July 1, 2014
Accepted: October 14, 2014
Published online: December 28, 2014

Abstract

A wide variety of surgical related uptake has been reported on F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (FDG PET/CT) scan, most of which can be differentiated from neoplastic process based on the pattern of FDG uptake and/or anatomic appearance on the integrated CT in image interpretation. A more potential problem we may be aware is postoperative reactive lymphadenitis, which may mimic regional nodal metastases on FDG PET/CT. This review presents five case examples demonstrating that postoperative reactive lymphadenitis could be a false-positive source for regional nodal metastasis on FDG PET/CT. Surgical oncologists and radiologists should be aware of reactive lymphadenitis in interpreting postoperative restaging FDG PET/CT scan when FDG avid lymphadenopathy is only seen in the lymphatic draining location from surgical site.

Key Words: Lymphadenitis, F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography, False-positive, Lymphadenopathy

Core tip: On restaging F18-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography for oncologic patients, a potential problem we may be aware is postoperative reactive lymphadenitis, which may mimic regional nodal metastases. The size and intensity of FDG uptake of the lymph nodes cannot be reliably used for differentiation of reactive lymphadenitis from regional nodal metastasis. Surgical oncologists and radiologists should be aware of reactive lymphadenitis when FDG avid lymphadenopathy is only seen in the lymphatic draining location from surgical site.



INTRODUCTION

Today metabolic imaging positron emission tomography/computed tomography (PET/CT) with F18-fluoro-2-deoxy-D-glucose (FDG) has gained widespread clinical applications in oncology, and is accepted as a standard care in many malignancies. FDG is an analog of glucose and is used as a tracer of glycolysis. Malignant tissue and cells often demonstrate increased rate of glycolysis for rapid proliferation, due to increased number of glucose transporter protein and increased intracellular hexokinase and phosphofructokinase levels[1,2]. FDG uptake is semi-quantitatively measured in the form of the standardized uptake value (SUV). However, FDG is not cancer-specific. Increased FDG uptake can be seen in many benign diseases or non-neoplastic conditions, most of which are inflammation or infection[3-7].

Surgical resection of tumor is a first or best treatment in many malignancies. Postoperative PET/CT is often obtained for restaging or detection of residual/recurrent disease. Although it is generally recommended that follow-up scan should be obtained at least 6 wk following surgery when postsurgical inflammation has subsided, a wide variety of types of surgical related uptake have been reported on FDG PET/CT scans[8-14]. Most of them can be differentiated from neoplastic process based on the pattern of FDG uptake and/or anatomic appearance on the integrated CT, although some may cause false-positive interpretation.

A more potential postoperative false-positive FDG PET/CT finding is reactive lymphadenitis, which is encountered in clinical practice but is not well described in the literature. The followings are a few case examples of postoperative reactive lymphadenitis, which all mimic regional nodal metastases on FDG PET/CT.

CASE EXAMPLES
Case 1

A 55-year-old woman had history of T2aN0Mx sarcoma of the left ankle, status post surgical resection with free margins. A preoperative FDG PET/CT was negative for regional lymphadenopathy. Repeat FDG PET/CT 3 mo postoperatively showed a new 2.3 cm left inguinal lymph node with intense uptake, suspicious for nodal metastasis. Biopsy of the node revealed reactive lymphadenitis (Figure 1).

Figure 1
Figure 1 Axial image of F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography obtained 3 mo postoperatively in a 55-year-old woman with history of T2aN0Mx myxofibrosarcoma of the left ankle. Compared to preoperative image, there was a new 2.3 cm left inguinal lymph node with intense uptake (SUV 8.0, arrows), suspicious for nodal metastasis. Biopsy of the node revealed reactive lymphadenitis. SUV: Standardized uptake value.
Case 2

A 68-year-old woman had history of vulvar squamous cell carcinoma, status post lesion resection and left inguinal node dissection. Repeat FDG PET/CT 5 mo postoperatively showed a new 1.5 cm left inguinal lymph node with increased uptake, suspicious for nodal metastasis. Incisional biopsy of the node suggested lymphadenitis (Figure 2).

Figure 2
Figure 2 Axial image of F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography obtained 5 mo postoperatively in a 68-year-old woman with history of vulvar squamous cell carcinoma. Compared to preoperative image, there was a new 1.5 cm left inguinal lymph node with increased uptake (SUV 4.9, arrows). Incisional biopsy of the node suggested lymphadenitis. SUV: Standardized uptake value.
Case 3

A 16-year-old woman had alveolar soft tissue sarcoma of the left knee, status post surgical resection and chemoradiation. Preoperative image was negative for inguinal lymphadenopathy. Repeat FDG PET/CT 6 mo postoperatively showed a new 1.4 cm left inguinal lymph node with intense uptake, suspicious for nodal metastasis. Incisional biopsy indicated lymphadenitis (Figure 3).

Figure 3
Figure 3 Axial image of F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography obtained 6 mo postoperatively in a 16-year-old woman with alveolar soft tissue sarcoma of the left knee. Compared to preoperative image, there was a new 1.4 cm left inguinal lymph node with intense uptake (SUV 5.2, arrows). Incisional biopsy confirmed lymphadenitis. SUV: Standardized uptake value.
Case 4

A 60-year-old man had history of tongue cancer, status post chemotherapy, radiation and bilateral neck dissection. The patient developed osteoradionecrosis of the jaws after radiation therapy. FDG PET/CT 6 mo postoperatively demonstrated a 2.6 cm × 1.5 cm right axillary lymph node with intense uptake (SUV 6.1, arrows), suspicious for metastasis. Biopsy of the node suggested chronic lymphadenitis with reactive lymphoid hyperplasia (Figure 4).

Figure 4
Figure 4 Axial image of F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography obtained 6 mo postoperatively in a 60-year-old man had history of tongue cancer. The image demonstrated a 2.6 cm x 1.5 cm right axillary lymph node with intense uptake (SUV 6.1, arrows), suspicious for metastasis. Biopsy of the node suggested chronic lymphadenitis with reactive lymphoid hyperplasia. SUV: Standardized uptake value.
Case 5

A 77-year-old woman had history of right breast cancer, status post lumpectomy. FDG PET/CT 3 mo postoperatively showed a few FDG avid right axillary lymph nodes, the largest 1.6 cm with SUV 5.1 (arrows), highly suspicious for regional nodal metastases. Subsequent biopsy was indicative of reactive lymphadenitis (Figure 5).

Figure 5
Figure 5 Axila image of F18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography obtained 3 mo postoperatively in a 77-year-old woman had history of right breast cancer. There were a few FDG avid right axillary lymph nodes, the largest 1.6 cm with SUV 5.1 (arrows), all new compared to prior images. The findings were highly suspicious for regional nodal metastases. Subsequent biopsy was indicative of reactive lymphadenitis. SUV: Standardized uptake value.
DISCUSSION

Postoperative FDG PET/CT is often obtained for restaging or detection of residual/recurrent tumor. Increased FDG uptake can be seen in the surgical site in the early postoperative period as a consequence of leukocyte infiltrate and granulation tissue involved in would healing and absorption of necrotic debris and hematoma. Various kinds of postoperative complications have been reported on FDG PET/CT. Makis et al[14] reported 9 cases with incidental infectious or inflammatory findings on FDG PET/CT, in patients with prior surgical intervention that was part of the management of oncologic care. These included surgical wound infection, fistulas, abscess, and mesh infection. On image interpretation, most of surgery-related changes and/or inflammation can be identified without many difficulties based on the pattern of FDG uptake and CT findings.

Inflammatory/infectious lymphadenitis has been well recognized with increased FDG uptake on PET/CT, such as in the tuberculosis[15,16], Kikuchi disease[17,18], toxoplasmosis[19], various viral infections including HIV[20,21], etc. False-positive lymph nodes had also been reported[22-24] on FDG PET/CT in oncologic patients. Tsukada et al[22] reported a case with false-positive mediastinal lymph nodes on FDG PET/CT in rectal cancer patient. Ataergin et al[23] reported 3 cases of tuberculosis lymphadenitis detected on FDG PET scan in patients with concomitant cancer diagnosis. Park et al[24] described false-positive tuberculous mediastinal lymphadenitis on FDG PET/CT in a melanoma patient. In all these cases, however, false-positive lymphadenitis on FDG PET/CT was not related to primary tumors in the locations, and not secondary to surgical resections of primary tumors.

Postoperative lymphadenitis is not well defined in the literatures. Regional lymphadenopathy may develop postoperatively due to an inflammatory response to the surgery, but it is typically days after the surgery and less than 1.0 cm in size[25]. In the case examples above, FDG PET/CT was all obtained 3, 5, and 6 mo postoperatively when postoperative reaction and/or inflammation has subsided in general. The regional FDG avid lymph nodes were all located in the ipsilateral side of primary tumors and surgical procedures, and were new compared to preoperative PET/CT scans. Although FDG avid lymphadenopathy was only seen in the single location on the lymphatic draining route from the primary lesion and surgical site, CT features such as large size and solid appearance, and high FDG avidity of the lymph nodes were all suspicious for regional nodal metastases. However, surgical pathology revealed reactive lymphadenitis most likely secondary to surgical procedure. In these cases, the differentiation between regional nodal metastasis and reactive lymphadenitis was very challenging based on imaging only, and pathological diagnosis might be warranted. SUV cannot reliably discriminate between inflammation/infection and tumor.

CONCLUSION

Surgical oncologists and radiologists should be aware of reactive lymphadenitis on interpreting postoperative restaging FDG PET/CT scan when FDG avid lymphadenopathy is only seen in the lymphatic draining location from surgical site. The size and intensity of FDG uptake of the lymph nodes cannot be reliably used for differentiation of reactive lymphadenitis from regional nodal metastasis. Postoperative reactive lymphadenitis could be a potential false-positive source for regional nodal metastasis on FDG PET/CT.

Footnotes

P- Reviewer: Li YZ, Stack BC, Treglia G S- Editor: Tian YL L- Editor: A E- Editor: Lu YJ

References
1.  Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med. 2010;40:294-315.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 83]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
2.  Chang JM, Lee HJ, Goo JM, Lee HY, Lee JJ, Chung JK, Im JG. False positive and false negative FDG-PET scans in various thoracic diseases. Korean J Radiol. 2006;7:57-69.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
3.  Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Hernandez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26:671-687.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
4.  Asad S, Aquino SL, Piyavisetpat N, Fischman AJ. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol. 2004;182:983-989.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 58]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
5.  Metser U, Miller E, Lerman H, Even-Sapir E. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. AJR Am J Roentgenol. 2007;189:1203-1210.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 112]  [Cited by in F6Publishing: 105]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
6.  Metser U, Even-Sapir E. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT. Semin Nucl Med. 2007;37:206-222.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 151]  [Cited by in F6Publishing: 165]  [Article Influence: 9.7]  [Reference Citation Analysis (0)]
7.  Wang X, Koch S. Positron emission tomography/computed tomography potential pitfalls and artifacts. Curr Probl Diagn Radiol. 2009;38:156-169.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 32]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
8.  Dubroff JG, Alavi A, Friedberg JS, Cengel KA. Postsurgical atypical F-18 fluorodeoxyglucose positron emission tomography uptake. Clin Nucl Med. 2009;34:808-810.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
9.  Adejolu M, Huo L, Rohren E, Santiago L, Yang WT. False-positive lesions mimicking breast cancer on FDG PET and PET/CT. AJR Am J Roentgenol. 2012;198:W304-W314.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 89]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
10.  Takahara K, Kakinoki H, Ikoma S, Udo K, Tobu S, Satoh Y, Tokuda Y, Noguchi M, Aoki S, Uozumi J. Suture granuloma showing fasle-positive finding on FDG-PET. Case Reports in Urol. 2013;2013:472642.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 12]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
11.  Ruiz-Zafra J, Rodríguez-Fernández A, Sánchez-Palencia A, Cueto A. Surgical adhesive may cause false positives in integrated positron emission tomography and computed tomography after lung cancer resection. Eur J Cardiothorac Surg. 2013;43:1251-1253.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 9]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
12.  Liu Y. Orthopedic surgery-related benign uptake on FDG-PET: case examples and pitfalls. Ann Nucl Med. 2009;23:701-708.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 9]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
13.  Bhargava P, Rahman S, Wendt J. Atlas of confounding factors in head and neck PET/CT imaging. Clin Nucl Med. 2011;36:e20-e29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
14.  Makis W, Ciarallo A, Rush C, Hickeson M. Infectious and inflammatory complications of surgical management of cancer patients imaged with 18F-FDG PET/CT: a pictorial essay. Clin Imaging. 2013;37:669-679.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
15.  Enomoto K, Hoshida Y, Hamada K, Okada T, Kubo T, Hatazawa J. F-18 FDG PET imaging of cervical tuberculous lymphadenitis. Clin Nucl Med. 2007;32:474-475.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
16.  Sathekge M, Maes A, D’Asseler Y, Vorster M, Gongxeka H, Van de Wiele C. Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease. Eur J Nucl Med Mol Imaging. 2012;39:1184-1190.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 29]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
17.  Kong E, Chun K, Hong Y, Hah J, Cho I. 18F-FDG PET/CT findings in patients with Kikuchi disease. Nuklearmedizin. 2013;52:101-106.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 10]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
18.  Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, Shimizu K, Tsuji K, Okazawa H, Kimura H. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011;36:661-664.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
19.  Treglia G, Bongiovanni M, Ceriani L, Paone G, Giovanella L. Toxoplasmic Lymphadenitis Mimicking a Metastatic Thyroid Carcinoma at (18)F-FDG-PET/CT. Nucl Med Mol Imaging. 2013;47:289-290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
20.  Sathekge M, Maes A, Van de Wiele C. FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med. 2013;43:349-366.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 80]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
21.  Thomas DL, Syrbu S, Graham MM. Epstein-Barr virus mimicking lymphoma on FDG-PET/CT. Clin Nucl Med. 2009;34:891-893.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
22.  Tsukada T, Nakano T, Matoba M, Sasaki S, Higashi K. False-Positive Mediastinal Lymphadenopathy on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography after Rectal Cancer Resection: A Case Report of Thoracoscopic Surgery in the Prone Position. Case Rep Oncol. 2011;4:569-575.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
23.  Ataergin S, Arslan N, Ozet A, Ozguven MA. Abnormal FDG uptake on F18-fluorodeoxyglucose positron emission tomography in patients with cancer diagnosis: case reports of tuberculosis lymphadenitis. Inter Med. 2009;48:115-119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
24.  Park WJ, Kim EK, Park JH. Extensive tuberculous lymphadenitis mimicking distant lymph node metastasis on F-18FDG PET/CT in a patient with a history of malignant melanoma. Yonsei Med J. 2013;54:1554-1556.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
25.  Scialpi M, Scaglione M, Volterrani L, Lupattelli L, Ragozzino A, Romano S, Rotondo A. Imaging evaluation of post pancreatic surgery. Eur J Radiol. 2005;53:417-424.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 41]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]